Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-0500
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Risk factors for mortality of patients with ceftriaxone resistant E. coli bacteremia receiving carbapenem versus beta lactam/beta lactamase inhibitor therapy ; volume:12 ; number:1 ; day:23 ; month:9 ; year:2019 ; pages:1-5 ; date:12.2019
BMC Research Notes / Biomed Central; 12, Heft 1 (23.9.2019), 1-5, 12.2019
- Creator
-
Nasir, Nosheen
Ahmed, Sara
Razi, Samrah
Awan, Safia
Mahmood, Syed Faisal
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13104-019-4648-7
- URN
-
urn:nbn:de:101:1-2020020218250402908415
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nasir, Nosheen
- Ahmed, Sara
- Razi, Samrah
- Awan, Safia
- Mahmood, Syed Faisal
- SpringerLink (Online service)
Other Objects (12)
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
Genetic associations in beta-lactam allergy
![Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group
Cefoxitin, ein β-Lactamase-stabiles [Beta-Lactamase-stabiles] Antibiotikum
β-Lactamase-Produktion [Beta-Lactamase-Produktion] durch Acinetobacter calcoaceticus
β [Beta]-Lactam-Synthesen mit siliciumorganischen Verbindungen
Synthese, Struktur und Reaktivität von neuen β-Lactam-Verbindungen [Beta-Lactam-Verbindungen]
Synthese und biologische Aktivität neuer nichtklassischer β-Lactam-Antibiotika [Beta-Lactam-Antibiotika]
Cephalosporins as key lead generation beta-lactam antibiotics
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
Genetic associations in beta-lactam allergy
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group
Cefoxitin, ein β-Lactamase-stabiles [Beta-Lactamase-stabiles] Antibiotikum
β-Lactamase-Produktion [Beta-Lactamase-Produktion] durch Acinetobacter calcoaceticus
β [Beta]-Lactam-Synthesen mit siliciumorganischen Verbindungen
Synthese, Struktur und Reaktivität von neuen β-Lactam-Verbindungen [Beta-Lactam-Verbindungen]
Synthese und biologische Aktivität neuer nichtklassischer β-Lactam-Antibiotika [Beta-Lactam-Antibiotika]
Cephalosporins as key lead generation beta-lactam antibiotics
Serious adverse events with novel beta-lactam/beta-lactamase inhibitor combinations: a large-scale pharmacovigilance analysis
Microbiology of Meropenem-Vaborbactam: A Novel Carbapenem Beta-Lactamase Inhibitor Combination for Carbapenem-Resistant Enterobacterales Infections
Rationale and evidence for the use of new beta-lactam/beta-lactamase inhibitor combinations and cefiderocol in critically ill patients
Genetic associations in beta-lactam allergy
Neue semisynthetische β-Lactam-Antibiotika [Beta-Lactam-Antibiotika] aus Arylpyrrolidoncarbonsäuren
Potential involvement of beta-lactamase homologous proteins in resistance to beta-lactam antibiotics in gram-negative bacteria of the ESKAPEE group
Cefoxitin, ein β-Lactamase-stabiles [Beta-Lactamase-stabiles] Antibiotikum
β-Lactamase-Produktion [Beta-Lactamase-Produktion] durch Acinetobacter calcoaceticus
β [Beta]-Lactam-Synthesen mit siliciumorganischen Verbindungen
Synthese, Struktur und Reaktivität von neuen β-Lactam-Verbindungen [Beta-Lactam-Verbindungen]
Synthese und biologische Aktivität neuer nichtklassischer β-Lactam-Antibiotika [Beta-Lactam-Antibiotika]